[Expert consensus on Shujin Jianyao Pills in clinical practice].

Abstract

Shujin Jianyao Pills is a Chinese patent medicine, with anti-inflammation, analgesic and anti-osteoporotic effects. Based on a questionnaire investigation of clinicians and a systematic review of study literatures on Shujin Jianyao Pills, the international clinical practice guidelines development method was adopted to analyze the optimal available evidences and expert experiences in the "evidence-based, consensus-based and experience-based" principles. Expert consensus on Shujin Jianyao Pills in clinical practice(GS/CACM267-2019) was developed by more than 30 multidisciplinary experts nationwide with the aim to guide and standardize the rational use of Shujin Jianyao Pills among clinicians and improve the clinical efficacy and safety. The expert consensus adopted the internationally recognized recommendation criteria for classification of evidence--GRADE. Expert consensus was formed by the nominal group method. Six main considerations were quality of evidence, curative effect, safety, economical efficiency, patient acceptability and other factors. If there were sufficient evidences, a "recommendation" was given, and GRADE grid voting rule was adopted. If there wasn't sufficient evidence, a "consensus opinion" was formed, and the majority counting rule. According to the indication, usage and do-sage, drug use for special population and safety of Shujin Jianyao Pills, one recommendation and nine consensus opinions were put forward. By means of expert meetings and correspondence, a nationwide consultations and peer reviews were conducted. This consensus is applicable to clinicians in hospitals and grass-roots health services, and provides guidance and reference for the rational use of Shujin Jianyao Pills.

• Authors: Huan Liu, Jing-Hua Gao, Yan-Ming Xie, Yuan-Yuan Li, Ling Zhang, Sheng-Hua Li, Zu-Jian Xu, Feng Huang, Gang Li, Yong-Yan Wang
• Journal: Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica (Zhongguo Zhong Yao Za Zhi) Vol. 45 Issue 10 Pg. 2300-2303 (May 2020) ISSN: 1001-5302 [Print] China
• PMID: 32495584 (Publication Type: Journal Article, Systematic Review)

Chemical References

• Drugs, Chinese Herbal
• Nonprescription Drugs

Topics

• Consensus
• Drugs, Chinese Herbal
• Humans
• Inflammation
• Medicine, Chinese Traditional
• Nonprescription Drugs